853029-57-9: 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine

1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine ( CAS No: 853029-57-9) or 8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2- quinazolinyl)methyl]-1H-purine-2,6-dione is a Dipeptidyl Peptidase-4 Inhibitor which is used in e treatment of Type-II Diabetes.

Additional information

Catalogue No.

VE007277

CAS No.

853029-57-9

Molecular Formula

C20H17BrN6O2

Molecular Weight

453.29 g/mol

IUPAC Name

8-Bromo-7-(2-butyn-1-yl)-3, 7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2, 6-dione

References

“Sci-Hub, Linagliptin: A Novel Methylxanthin Based Approved Dipeptidyl Peptidase-4 Inhibitor, 10.2174/138945012800675731.” Hkvisa.net, 2012, sci-hub.hkvisa.net/10.2174/138945012800675731.

Status

In-stock